Shengxiang Biology, Haoyuan Medicine, and other newly established venture capital funds.

According to the Enterprise Search APP, the Guangzhou Shengquan Baijie Entrepreneurship Investment Fund Partnership Enterprise was recently established with a capital contribution of 150 million yuan. Its business scope includes entrepreneurial investment; engaging in equity investment, investment management, asset management and other activities with private equity funds. Equity penetration information from Enterprise Search shows that the enterprise is jointly invested by Shengxiang Biology, Haoyuan Medicine, Lai Mei Pharmaceutical and others.